Mustang Bio, Inc.
MBIO
$1.09
-$0.08-6.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -952.00K | -1.41M | -8.20M | -5.19M | -8.62M |
| Total Depreciation and Amortization | 75.00K | 51.00K | 1.00K | 696.00K | 363.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 2.09M | 71.00K | 1.91M | 76.00K | 1.10M |
| Change in Net Operating Assets | -3.21M | -469.00K | 3.95M | -902.00K | -101.00K |
| Cash from Operations | -2.00M | -1.76M | -2.34M | -5.32M | -7.25M |
| Capital Expenditure | -- | -- | -- | -- | -30.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -- | -30.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 5.56M | 1.16M | 5.95M | 49.00K | 4.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -626.00K | -149.00K | -680.00K | -- | -442.00K |
| Cash from Financing | 4.94M | 1.01M | 5.27M | 49.00K | 3.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.94M | -743.00K | 2.93M | -5.27M | -3.33M |